Biocon Ltd.: Building a Biotech Powerhouse
9B06M070
-
- $3.99
-
- $3.99
Publisher Description
The founder chairman and managing director wants to make Biocon, Ltd. one of the top 10 biotech firms by 2015. The company has dealt in low-risk enzymes and generic drugs for many years. In order for the company to grow, the chairman believes that Biocon must enter the riskier business of drug discovery and development. Without making large investments into new capabilities, the company cannot become a top 10 biotech firm.
GENRE
Business & Personal Finance
RELEASED
2006
October 12
LANGUAGE
EN
English
LENGTH
15
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
2
MB
Chromos Molecular Systems Inc.
2001
Hybridon, Inc.
2002
Shire Pharmaceuticals Group's Acquisition of Biochem Pharma: Broadening Product Portfolio and Achieving Economies of Scale in Pharmaceuticals
2003
Cambridge Laboratories: Proteomics
2004
Dr. Reddy's Laboratories (A)
2008
Accounting at Biovail
2004